baCta
3 known investors
BACTA is an AI-powered bioproduction company that uses microorganisms to produce industrial ingredients such as astaxanthin for cosmetics, human nutrition, and animal nutrition markets.
Investors · 3
Competitors · 4
by search overlapIota5 shared keywordsiota Biosciences develops bioelectronic therapies, working on medical device technologies for therapeutic applications.
Biotax5 shared keywordsEcoBiotaX develops a microbial ecology platform that uses AI (its ecoSat computational platform) and biological methods to discover and construct natural bacterial communities for specific biological functions. It targets applications in health, food, agriculture, and climate.
Hepta5 shared keywordsHepta develops LiquidTransformer, an AI platform for analyzing cell-free DNA fragments in blood to detect chronic disease molecular signals. The platform uses transformer-based models with attention mechanisms to identify disease biomarkers from liquid biopsy samples.
Predictabiosciences3 shared keywordsPredicta Biosciences operates a molecular insights platform for blood cancer care, using whole genome sequencing of intact circulating tumor cells from a single blood sample combined with single-cell immune profiling to characterize disease biology and immune response. Its diagnostics serve clinicians, researchers, and pharmaceutical partners working in hematological malignancies such as multiple myeloma.
Companies competing with baCta for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does baCta do?
- BACTA is an AI-powered bioproduction company that uses microorganisms to produce industrial ingredients such as astaxanthin for cosmetics, human nutrition, and animal nutrition markets.
- Who are baCta's investors?
- baCta's investors include Agoranov, Daphni, OVNI Capital.